What is Oxígeno Medicinal Líquido Solgroup used for?

Oxígeno Medicinal Líquido Solgroup

Active Ingredient:: Oxygen
Origin:: EU

Oxígeno Medicinal Líquido Solgroup (Oxygen)

Oxygen, the active ingredient in Oxígeno Medicinal Líquido Solgroup, is a medical gas presented as a liquid for inhalation use. It is used to increase oxygen levels in patients with respiratory insufficiency and during medical procedures that require supplemental oxygen. GNH India supplies Oxígeno Medicinal Líquido Solgroup as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH India supplies Oxígeno Medicinal Líquido Solgroup as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Sol Spa

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxígeno Medicinal Líquido Solgroup is used to provide supplemental oxygen in clinical situations that involve impaired gas exchange.

Respiratory distress: Improves oxygen saturation in patients experiencing acute or chronic breathing difficulties.
Pre‑operative preparation: Increases oxygen reserves before anesthesia induction.
Hyperbaric therapy support: Supplies oxygen for use in hyperbaric oxygen chambers.
Emergency care: Delivers rapid oxygenation during trauma or cardiac arrest scenarios.
Post‑operative recovery: Assists in maintaining adequate oxygen levels during the immediate recovery period.

How It Works

Oxygen acts as the final electron acceptor in cellular respiration, enabling aerobic metabolism and ATP production. When administered as a medical gas, it diffuses across alveolar membranes into the bloodstream, raising arterial oxygen tension and supporting tissue oxygenation throughout the body.

Side Effects

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects

Nasal dryness: Mild irritation of the nasal mucosa.
Headache: Transient headache due to changes in blood gas levels.
Cough: Irritation of the airway leading to a cough reflex.
Fatigue: Feeling of tiredness after prolonged exposure.

Serious or Rare Side Effects

Fire hazard: Increased risk of combustion in the presence of an open flame.
Oxygen toxicity: Pulmonary or central nervous system toxicity from high concentrations.
Barotrauma: Lung injury due to pressure changes during delivery.
Visual disturbances: Temporary changes in vision with high flow rates.

Precautions & Warnings

When using Oxígeno Medicinal Líquido Solgroup, follow these safety measures:

Patient assessment: Evaluate respiratory status and oxygen saturation before initiation.
Flow rate selection: Adjust to maintain target SpO2 levels as prescribed.
Monitoring: Continuously monitor vital signs and signs of hypoxia.
Equipment compatibility: Ensure delivery devices are compatible with liquid oxygen.
Fire safety: Keep away from open flames and smoking materials.
Store at ambient temperature: Keep container in a well‑ventilated area, protected from direct sunlight and moisture.

Avoid Interactions

Oxygen may interact with certain therapies and environmental factors.

Major Interactions (Avoid)

Flammable anesthetics: Increased fire risk when combined with volatile agents.
Nitrogen oxides: Can reduce the effectiveness of supplemental oxygen.

Moderate Interactions (Monitor Closely)

Bronchodilators: May enhance bronchodilation effects.
Sedatives/analgesics: May mask hypoventilation signs.
Hyperbaric chambers: Requires careful pressure monitoring.
High‑flow nasal cannula systems: Adjust settings to avoid excessive FiO2.
Carbon dioxide retention: Monitor patients with COPD for CO2 buildup.

Frequently Asked Questions

Oxígeno Medicinal Líquido Solgroup provides supplemental oxygen to patients who need increased oxygen levels, such as those with respiratory distress, during pre‑operative preparation, in hyper‑baric therapy …

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 11 Oct 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.